[Immunotherapy of melanoma].
Dummer
R
R
Dermatologische Klinik, Universitätsspital Zürich. dummer@derm.unizh.ch
Nestle
F O
FO
Burg
G
G
D019496:Cancer Vaccines; D016207:Cytokines / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D008545:Melanoma / Q000401:mortality / Q000628:therapy*; D009362:Neoplasm Metastasis; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000401:mortality / Q000628:therapy*; D013997:Time Factors; D014611:Vaccination
D019496:Cancer Vaccines; D016207:Cytokines; D016898:Interferon-alpha; D007376:Interleukin-2